Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury

Few intravenously administered mesenchymal stromal cells (MSCs) engraft to the injured myocardium, thereby limiting their therapeutic efficacy for the treatment of ischemic heart injury. Here, it is found that irisin pretreatment increases the cardiac homing of adipose tissue‐derived MSCs (ADSCs) ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wenjun, Chen, Youhu, Guo, Yongzhen, Xia, Yunlong, Li, Congye, Du, Yunhui, Lin, Chen, Xu, Xiaoming, Qi, Tingting, Fan, Miaomiao, Zhang, Fuyang, Hu, Guangyu, Gao, Erhe, Liu, Rui, Hai, Chunxu, Tao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895138/
https://www.ncbi.nlm.nih.gov/pubmed/35038246
http://dx.doi.org/10.1002/advs.202103697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895138/
https://www.ncbi.nlm.nih.gov/pubmed/35038246
http://dx.doi.org/10.1002/advs.202103697

Ejemplares similares